Financials
Income statement
Fiscal date | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
---|---|---|---|---|
Total reported revenue | 3.3T | 2.7T | 2.9T | 3.0T |
Cost of revenue | 2.4T | 1.9T | 2.0T | 2.1T |
Gross profit | 927.3B | 790.2B | 848.8B | 888.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 127.7B | 59.3B | 124.2B | 168.9B |
Non operating interest income | ||||
Income | 2.2B | 3.9B | 4.2B | 3.0B |
Expense | 16.9B | 13.2B | 11.6B | 10.7B |
Other income expense | — | — | — | — |
Pretax income | 53.7B | 37.4B | 55.1B | 146.1B |
Tax provision | 18.9B | 14.8B | 11.4B | 41.6B |
Net income | 34.8B | 22.7B | 43.7B | 104.5B |
Basic EPS | — | 8.2 | — | — |
Diluted EPS | — | 8.2 | — | — |
Basic average shares | — | 2.6B | — | — |
Diluted average shares | — | 2.6B | — | — |
EBITDA | 276.7B | 198.9B | 264.8B | 303.0B |
Net income from continuing op. | 53.7B | 37.4B | 55.1B | 146.1B |
Minority interests | -4.0B | -1.3B | -1.2B | -2.6B |
Preferred stock dividends | 0 | 0 | 0 | 0 |